论文部分内容阅读
目的常规超声对肝癌射频消融联合无水乙醇治疗后疗效评估较为困难,文中探讨超声造影(contrast-enhancedultrasonography,CEUS)评估射频消融(radiofrequency ablation,RFA)联合无水乙醇注射(percutaceous ethanol injection,PEI)治疗肝癌局部疗效的临床价值。方法应用CEUS对167例肝癌患者的194个病灶行RFA/PEI/RFA+PEI治疗后局部疗效评估,并与同期常规彩超(color doppler ultrasound,